Generate Biomedicines (GENB) Income Statement

Generate Biomedicines reported revenue of $31.89M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 55.9% from $20.46M a year earlier. Generate Biomedicines posted a net loss of $249.52M, compared with a net loss of $173.77M a year earlier. Gross margin was 100.0% and operating margin -737.0%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $6.31M, down 37.7% from the same quarter a year earlier.

Generate Biomedicines Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Generate Biomedicines, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024
Period ending	Dec 2025	Dec 2024
Revenue & Gross Profit
Revenue	31.89	20.46
Cost of Revenue	224.70	0.00
Gross Profit	31.89	20.46
Operating Expenses
Research & Development	224.70	175.31
Selling, General & Administrative	42.26	42.09
Operating Expenses	266.96	217.40
Operating Income	-235.07	-196.94
Other Income/Expense
Interest Income	13.66	18.12
Interest Expense	1.14	2.12
Other Income/Expense	12.26	15.77
Income
Income Before Tax	-222.80	-181.17
Income Tax Expense	-0.16	0.21
Net Income	-249.52	-173.77
Net Income - Continuous Operations	-203.15	-173.77
Net Income - Discontinued Operations	-	-
EBITDA	-221.89	-163.71
EBIT	-235.07	-179.05
Depreciation & Amortization	13.18	15.35
Earnings Per Share
Basic EPS	-5.00	-2.00
Diluted EPS	-8.00	-2.00
Basic Shares Outstanding	50.09	127.45
Diluted Shares Outstanding	50.09	127.45

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Generate Biomedicines Financial Statements

What was Generate Biomedicines's revenue in fiscal 2025?

Generate Biomedicines reported revenue of $31.89M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 55.9% from $20.46M a year earlier.

Is Generate Biomedicines profitable?

No. Generate Biomedicines reported a net loss of $249.52M in fiscal 2025. In fiscal 2024 it lost $173.77M.

What is Generate Biomedicines's operating margin?

Generate Biomedicines's operating income was −$235.06M on revenue of $31.89M in fiscal 2025, an operating margin of -737.0%, compared with -962.6% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition